PHEOCHROMOCYTOMA/PARAGANGLIOMA (PPGL)
Clinical trials for PHEOCHROMOCYTOMA/PARAGANGLIOMA (PPGL) explained in plain language.
Never miss a new study
Get alerted when new PHEOCHROMOCYTOMA/PARAGANGLIOMA (PPGL) trials appear
Sign up with your email to follow new studies for PHEOCHROMOCYTOMA/PARAGANGLIOMA (PPGL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New PET tracer may outshine standard scan for rare tumors
Diagnosis Recruiting nowThis study tests a newer PET/CT tracer (Al18F-NOTA-LM3) against the standard one (68Ga-DOTATATE) to see which finds more tumors in people with pheochromocytoma or paraganglioma (PPGL). About 40 adults with suspected or confirmed PPGL will receive both scans. The goal is to improv…
Matched conditions: PHEOCHROMOCYTOMA/PARAGANGLIOMA (PPGL)
Phase: NA • Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated May 16, 2026 23:51 UTC
-
New PET tracer could spot hidden cancers better than current scans
Diagnosis Recruiting nowThis study is testing whether a new PET imaging tracer called [18F]FAPI-74 can find tumors as well as or better than the standard tracer in adults with certain cancers (like pancreatic, ovarian, or lung cancer). Participants will get both types of scans to compare how many tumors…
Matched conditions: PHEOCHROMOCYTOMA/PARAGANGLIOMA (PPGL)
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Diagnosis
Last updated May 16, 2026 23:49 UTC